螺內酯 / 安達通 Spironolactone × PCOS 症狀

結論:證據支持但有警示

螺內酯用於 PCOS 症狀(多毛、痤瘡、雄性禿)屬 OFF-LABEL 使用(FDA/EMA/TFDA 核准適應症皆為高血壓、心衰竭、肝硬化腹水、原發性醛固酮過多症),但具備強而一致的專科共識:Endocrine Society 2018 多毛症指引明確建議 100-200 mg/日為二線方案(PMID academic.

B 🟡 B 初步證據 附警語發布 low — community discussion mostly non-commercial
⚠️ 標記 🇹🇼 台灣在地警示

螺內酯用於 PCOS 症狀(多毛、痤瘡、雄性禿)屬 OFF-LABEL 使用(FDA/EMA/TFDA 核准適應症皆為高血壓、心衰竭、肝硬化腹水、原發性醛固酮過多症),但具備強而一致的專科共識:Endocrine Society 2018 多毛症指引明確建議 100-200 mg/日為二線方案(PMID academic.oup.com/jcem/103/4/1233),Mayo Clinic、Cleveland Clinic、Harvard Health 三大臨床機構均明確支持,PubMed 多篇 SR/MA(PMID 36999713 含 24 RCT;2026 Clin Endocrinol 5 RCT;PMID 37635987 metformin 合併)顯示對 hirsutism FG 分數與雄性素症狀有中等改善但對 BMI/HOMA-IR/LH/FSH/月經週期無效。

考量 off-label 但專家共識強且有 SR/MA 支持,定為 B(若為 on-label 心衰竭/高血壓則為 A)。

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.57
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 附警語發布
信心度
88%
證據方向一致性高
證據層級
E2
多篇高品質統合分析(≥2 篇一致)

各層「支持此療效」的程度

分數越低=該層越不支持
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
L11 AI 複核獨立判讀
0.65
L5 臨床機構權威立場
0.85
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.575
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More than an Anti-androgen? Evidence from a Systematic Review and Meta-analysis
PMID: 36999713 2023 統合分析
— 詳細結論請見 PubMed 原文
前往 PubMed
Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
PMID: 37635987 2023 統合分析
— 詳細結論請見 PubMed 原文
前往 PubMed
Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of rando…
PMID: 32248801 2020 Network Meta-analysis
— 詳細結論請見 PubMed 原文
前往 PubMed
Spironolactone Versus Oral Contraceptive Pills in the Treatment of Adolescent Polycystic Ovarian Syndrome: A Systematic Review
PMID: 2022 系統性回顧
— 詳細結論請見 PubMed 原文
前往 PubMed
Short-Term, Low-Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
PMID: 2026 統合分析
— 詳細結論請見 PubMed 原文
前往 PubMed

L4a US FDA
支持
Spironolactone has been shown to be a tumorigen in chronic toxicity studies in rats. Spironolactone should be used only in those conditions described under INDICATIONS AND USAGE. Unnecessary use of this drug should be avoided. ALDACTONE is indicated for: Treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hosp… 來源↗
L4b EU EFSA
支持
Qaialdo received marketing authorization on 26 May 2023. It is authorized to manage refractory oedema associated with congestive heart failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, and for diagnosis and treatment of primary aldosteronism and essential hypertension. The medicine can only be obtained with a prescription, and children should only be tre… 來源↗
L4c UK NHS
支持
It's used to treat: swelling, in the ankles, feet and other parts of the body, caused by fluid build-up (oedema), heart failure, high blood pressure (hypertension) if other medicines have not worked. It's only available with a prescription. Spironolactone is not usually recommended during pregnancy. This is because it can potentially affect a baby's development. [Serious side effects include] h… 來源↗
L4d TW TFDA / 衛福部
支持
安達通錠25 毫克 Aldactone Tablets 25 mg 衛署藥輸字第022610號 本藥須由醫師處方使用。適應症:利尿、高血壓、原發性醛類脂醇過多症。孕婦用藥分級:D 級。高血鉀症徵象(有高達26%病人發生,即使與Thiazide 利尿劑合用亦如此)。 來源↗
L4e WHO
支持
Spironolactone is an aldosterone receptor antagonist used to treat edema, hypertension, heart failure, and aldosteronism. More specifically, its antimineralocorticoid activity is responsible for its therapeutic efficacy in the treatment of edema, high blood pressure, heart failure, hyperaldosteronism, and ascites due to cirrhosis. Additionally, spironolactone reduces the rate of testosterone pr… 來源↗

L5a NIH Office of Dietary Supplements
支持
Spironolactone tablets are indicated for: (1) the treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure, and (2) use as an add-on therapy for the treatment of hypertension, to lower blood pressure. Additionally, spironolactone is indicated for the management of edema in adult pa… 來源↗
L5b Mayo Clinic
支持
The most commonly used anti-androgen for hirsutism treatment is spironolactone (Aldactone, CaroSpir). However, the results are modest and take at least six months to be seen. Side effects can include irregular periods, and these medicines also can cause birth defects, so it's important to use birth control while you take them. 來源↗
L5c Cleveland Clinic
支持
Hirsutism often responds well to birth control pills, spironolactone or both. ... Lowering your androgen levels with spironolactone or oral contraceptives can help you keep more hair on your head. ... This medication is safe for most adults recorded female at birth, but you shouldn't get pregnant while taking it because it can harm a developing fetus. 來源↗
L5d Harvard Health
支持
Dermatologists often recommend the use of oral contraceptive pills or a medication called spironolactone to treat this type of acne. ... Certain medications, including spironolactone and retinoids for acne, should be avoided if a woman is trying to become pregnant. 來源↗
L5e Specialty Society (condition-mapped)
支持
Spironolactone, an aldosterone antagonist, exhibits dose-dependent competitive inhibition of the androgen receptor as well as inhibition of 5α-reductase activity. Spironolactone 100-200 mg/d [given in divided doses (twice daily)]... As with all antiandrogens, if a patient inadvertently uses spironolactone during early pregnancy, there is a danger that a male fetus could be feminized. Spironolac… 來源↗

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 低度
📍立場總覽

TW 社群(PTT/Dcard/Mobile01/BabyHome)多囊版面以肌醇、Metformin、口服避孕藥為主軸,螺內酯/安達通討論度相對低;皮膚科部落格與藥師專欄則明確將其定位為 PCOS 二線抗雄激素用藥(OFF-LABEL,台灣 FDA 核可適應症為高血壓/水腫/原發性醛固酮症),通常在口服避孕藥使用 6 個月以上效果不佳時加入,用於改善多毛與痘痘。

💬社群實感

資料不足

破解迷思 社群最常見的 5 個誤解
事實誤以為安達通是 PCOS 的第一線藥,實際上台灣婦產科多以口服避孕藥(如 Diane-35、Yaz)為第一線,6 個月無效才加抗雄激素
事實誤以為短期內就會改善多毛,實際上多毛症需持續 6 個月以上才看得到效果
事實誤以為安達通在台灣是治療 PCOS 的核准適應症,實際為 OFF-LABEL,仿單適應症為高血壓、水腫、原發性醛固酮症
事實誤以為月經不規則代表藥物無效,實際是劑量相關的常見副作用(100–200 mg 高劑量幾乎都會發生)
事實誤以為可以與電解質補充劑或低鈉鹽併用,實際可能造成高血鉀危險
🩹 社群通報的副作用
  • 月經週期不規則、經間出血(中高劑量常見)
  • 頻尿、夜尿(>100 mg/day 明顯)
  • 乳房脹痛、乳房腫大
  • 高血鉀(嚴重時可致心律不整)
  • 頭暈、姿勢性低血壓、腸胃不適
🏷️ 社群熱議品牌

依論壇被提及頻率,非銷售或品質排序。

  • 安達通錠 Aldactone(輝瑞)
  • 愛達信錠 Aldactin(信東)
  • 保栓通(仿單同成分)
  • 皮膚科診所自費處方
  • 婦產科處方
  • 社區藥局調劑

⚠️ 列出僅代表「TW 社群討論度高」,不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

安達通錠25 毫克 Aldactone Tablets 25 mg 衛署藥輸字第022610號 本藥須由醫師處方使用

代表來源 ↗
L10b · TFDA 法定身份 官方認定
💊藥品(須醫師處方/指示)

安達通錠25 毫克 Aldactone Tablets 25 mg 衛署藥輸字第022610號 本藥須由醫師處方使用

來源 ↗

  • Metformin
  • 減重 5-10% + 規律運動
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 5 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v3 engine_version: v1.0 claim_id: CLM-COND-pcos-symptoms-INT-spironolactone-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-pcos-symptoms-INT-spironolactone-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "螺內酯 / 安達通能改善PCOS 症狀",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 3,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟡 B 初步證據"
  }
}